El Salvador

PATH is a leader in adapting health innovations with and for women across systems, populations, and geographies. This brief outlines PATH's vision, approach, and areas of expertise in Sexual and Reproductive Health.

This brief summarizes the experience and capabilities of the PATH Cervical Cancer Team. For decades, PATH has been at the forefront of evidence-based strategies from HPV vaccine research and delivery to cervical cancer screening and treatment to ensure we best meet the needs and realities of these countries for the greatest health impact.

Un modelo interactivo de Excel que evalúa las ventajas y desventajas de cuatro estrategias del tamizaje del cáncer cérvicouterino y cinco escenarios de tratamiento del precáncer cérvicouterino, al analizar la cantidad de mujeres alcanzadas, la eficacia del enfoque y los costos asociados. Haga clic en el enlace arriba para descargar el archivo Excel. CONSULTE LA NOTA ACLARATORIA EN LA HERRAMIENTA ANTES DE USAR.

Una hoja informativa que proporciona una descripción general de la Herramienta de Planificación para el Precáncer Cérvicouterino, incluidos los antecedentes, una descripción general de los escenarios y cómo la herramienta puede apoyar la planificación basada en evidencia.

An interactive Excel model that evaluates the trade-offs of four cervical cancer screening approaches and five cervical precancer treatment scenarios, looking at number of women reached, effectiveness of approach, and associated costs. Click the above link to download the Excel file. SEE DISCLAIMER IN TOOL BEFORE USE.

A fact sheet that provides an overview of the Cervical Precancer Planning Tool, including the background, a scenario overview, and how the tool can support evidence-based planning.

PATH’s Scale-Up project seeked to reduce cervical cancer incidence through improved and expanded screening using human papillomavirus (HPV) testing. Between 2015 and 2020, PATH partnered with countries in Central America to implement HPV testing for cervical cancer screening within public sector clinics. The project demonstrated that a new model of cervical cancer screening anchored on HPV testing is achievable. This resource shares the key findings and public health implications.

We're increasing the use of new technologies for cervical cancer screening and treatment in Central America.

This publication describes PATH’s efforts to examine the use and acceptability of maternal influenza immunization in El Salvador. The qualitative study captures the perspectives of pregnant women, family decision makers, community leaders, public health practitioners, private physicians, and more. The report identifies both successful strategies as well as challenges to vaccine uptake, and offers recommendations for countries considering the introduction of maternal influenza immunization.